These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4451751)

  • 1. Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools.
    Hughes J; Roth RH
    Br J Pharmacol; 1974 Jul; 51(3):373-81. PubMed ID: 4451751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.
    Hughes J
    Br J Pharmacol; 1972 Mar; 44(3):472-91. PubMed ID: 4339251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site(s) and ionic basis of alpha-autoinhibition and facilitation of "3H'noradrenaline secretion in guinea-pig vas deferens.
    Alberts P; Bartfai T; Stjärne L
    J Physiol; 1981 Mar; 312():297-334. PubMed ID: 6267264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation.
    Hughes J; Roth RH
    Br J Pharmacol; 1971 Feb; 41(2):239-55. PubMed ID: 4324592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for autoinhibition of stimulation-induced noradrenaline release from vasa deferentia of the guinea-pig and rat.
    McCulloch MW; Papanicolaou M; Rand MJ
    Br J Pharmacol; 1985 Oct; 86(2):455-64. PubMed ID: 2864973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in noradrenaline output with respect to stimulus frequency, train length and origin of the transmitter.
    Hughes J; Roth RH
    Br J Pharmacol; 1972 May; 45(1):157P. PubMed ID: 5041474
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential labelling of intraneuronal noradrenaline stores with different concentrations of (-)-3H-noradrenaline.
    Hughes J
    Br J Pharmacol; 1973 Feb; 47(2):428-30. PubMed ID: 4722053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens.
    Kalsner S
    J Pharmacol Exp Ther; 1980 Feb; 212(2):232-9. PubMed ID: 6101347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of post-ganglionic motor transmission in vas deferens by indirectly acting sympathomimetic drugs.
    Ambache N; Dunk LP; Verney J; Zar MA
    J Physiol; 1972 Dec; 227(2):433-56. PubMed ID: 4345926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of morphine on the release of noradrenaline from the mouse vas deferens.
    Henderson G; Hughes J
    Br J Pharmacol; 1976 Aug; 57(4):551-7. PubMed ID: 963343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dual 'small' vesicle model of ATP- and noradrenaline-mediated sympathetic neuromuscular transmission.
    Stjärne L
    Auton Neurosci; 2001 Feb; 87(1):16-36. PubMed ID: 11270138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of noradrenaline and dopamine by nerve stimulation in the guinea-pig and rat vas deferens.
    Bell C; Gillespie JS; Macrae IM
    Br J Pharmacol; 1984 Mar; 81(3):563-9. PubMed ID: 6697064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of noradrenaline and dopamine by nerve stimulation in the cat spleen perfused with 3 H-dopamine.
    Kirpekar SM; Yamamoto H
    Br J Pharmacol; 1971 Sep; 43(1):86-96. PubMed ID: 5136467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of reserpine-induced depletion of noradrenaline on the negative feed-back mechanism for transmitter release during nerve stimulation.
    Enero MA; Langer SZ
    Br J Pharmacol; 1973 Oct; 49(2):214-25. PubMed ID: 4367125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of noradrenaline release by adenosine.
    Wakade AR; Wakade TD
    J Physiol; 1978 Sep; 282():35-49. PubMed ID: 722535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of noradrenaline by splenic nerve stimulation and its dependence on calcium.
    Kirpekar SM; Misu Y
    J Physiol; 1967 Jan; 188(2):219-34. PubMed ID: 6030514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation-evoked release of [3H]-noradrenaline by 1, 10 or 100 pulses and its modification through presynaptic alpha 2-adrenoceptors.
    Marshall I
    Br J Pharmacol; 1983 Jan; 78(1):221-31. PubMed ID: 6297648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of blockade of noradrenaline re-uptake on evoked tritium overflow from mouse vasa deferentia and rat cortex slices.
    el-Mas M; Hughes IE
    Br J Pharmacol; 1990 Nov; 101(3):762-8. PubMed ID: 2076491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An electrophysiological analysis of the uptake of noradrenaline at sympathetic nerve terminals.
    Bennett MR
    J Physiol; 1973 Mar; 229(2):533-46. PubMed ID: 4724836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that prostaglandins inhibit the release of noradrenaline from adrenergic nerve terminals by restriction of availability of calcium.
    Hedqvist P
    Br J Pharmacol; 1976 Dec; 58(4):599-603. PubMed ID: 1000134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.